Block, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Block, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.19B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $24.12B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $21.92B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $17.53B | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $17.66B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $9.50B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $4.71B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $3.30B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $2.21B | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $1.71B | Feb 27, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $3.21B | Feb 27, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $2.21B | Feb 27, 2018 |
| FY2017 | Dec 31, 2016 | $1.71B | Feb 27, 2018 |
| FY2017 | Dec 31, 2015 | $1.27B | Feb 27, 2018 |
| FY2016 | Dec 31, 2014 | $850.19M | Feb 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.36B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.89B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $7.50B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $5.99B | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $4.42B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $2.73B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.89B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.30B | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $839.31M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $576.04M | Feb 27, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.31B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.90B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $9.77M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($540.75M) | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $166.28M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $213.11M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $375.45M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | ($38.45M) | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | ($62.81M) | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | ($171.59M) | Feb 27, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $892.33M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($278.84M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | ($624.53M) | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $161.11M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | ($18.82M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $26.56M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | ($36.61M) | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | ($54.21M) | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | ($170.45M) | Feb 27, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.91B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.91B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.72B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.14B | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $1.38B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $881.83M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $674.17M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $497.48M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $321.89M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $268.54M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.58B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.71B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $100.96M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $175.90M | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $847.83M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $173.11M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $327.63M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $295.08M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $127.71M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $23.13M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $155.04M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $153.95M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $151.15M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $170.82M | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $134.32M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $138.40M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $62.50M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $61.20M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $26.10M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $25.43M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.55B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $36.78B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $33.03B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $31.36B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $15.03B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $9.87B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $4.55B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $3.28B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.19B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.21B | Feb 27, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.38B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $15.54B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $14.34B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $14.11B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $11.71B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $7.19B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.84B | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | $2.16B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.40B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $635.21M | Feb 27, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.20B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $21.27B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $18.70B | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | $17.22B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.27B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.68B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.72B | Feb 23, 2021 |
| FY2020 | Dec 31, 2018 | $1.12B | Feb 23, 2021 |
| FY2020 | Dec 31, 2017 | $786.33M | Feb 23, 2021 |
| FY2019 | Dec 31, 2016 | $576.15M | Feb 26, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.85B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $11.42B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $11.92B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $11.97B | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $519.28M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $316.70M | Feb 23, 2023 |
| FY2021 | Jun 30, 2020 | $295.76M | Feb 24, 2022 |
| FY2021 | Dec 31, 2019 | $266.35M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $261.71M | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | $58.33M | Feb 26, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.67B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.37B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | ($528.43M) | Feb 24, 2025 |
| FY2023 | Dec 31, 2022 | ($568.71M) | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | ($27.97M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($297.22M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | ($510.33M) | Feb 23, 2021 |
| FY2019 | Dec 31, 2018 | ($885.77M) | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | ($842.74M) | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | ($779.24M) | Feb 27, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.56B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.08B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.00B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $4.54B | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | $4.44B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $3.16B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.05B | Feb 24, 2022 |
| FY2019 | Dec 31, 2018 | $583.17M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $696.47M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $452.03M | Feb 27, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 27, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 24, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 23, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 27, 2019 |